Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2008-12-30
2011-12-06
Raymond, Edward (Department: 2857)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C435S288400
Reexamination Certificate
active
08073632
ABSTRACT:
Methods and systems such as those described herein include accepting input, identifying CYP450-family enzymes, identifying at least one modulator of an enzyme, and communicating one or more treatments to a system user.
REFERENCES:
patent: 5658881 (1997-08-01), Gelland et al.
patent: 5731319 (1998-03-01), Aberg et al.
patent: 6037157 (2000-03-01), Norbeck et al.
patent: 6610489 (2003-08-01), Wolffe et al.
patent: 6625547 (2003-09-01), Korzekwa et al.
patent: 6673778 (2004-01-01), Iversen
patent: 6686338 (2004-02-01), Iversen
patent: 6790632 (2004-09-01), Zweig
patent: 6911438 (2005-06-01), Wright
patent: 7179597 (2007-02-01), Woosley
patent: 7208600 (2007-04-01), Cottrell et al.
patent: 7378422 (2008-05-01), Perni et al.
patent: 2002/0142950 (2002-10-01), Hayward et al.
patent: 2003/0023387 (2003-01-01), Gill-Garrison et al.
patent: 2003/0167135 (2003-09-01), Ewing
patent: 2003/0212497 (2003-11-01), Korzekwa et al.
patent: 2004/0052865 (2004-03-01), Gower et al.
patent: 2004/0180392 (2004-09-01), Prueksaritanont
patent: 2004/0229829 (2004-11-01), Iversen
patent: 2004/0241714 (2004-12-01), Branch et al.
patent: 2005/0049294 (2005-03-01), Palladino et al.
patent: 2005/0222071 (2005-10-01), Duranton et al.
patent: 2006/0178837 (2006-08-01), Gill-Garrison et al.
patent: 2006/0188562 (2006-08-01), Gower et al.
patent: 2006/0253263 (2006-11-01), Meshkin
patent: 2006/0289019 (2006-12-01), Marchand et al.
patent: 2007/0003931 (2007-01-01), Mrazek et al.
patent: 2007/0026480 (2007-02-01), Modak et al.
patent: 2007/0166816 (2007-07-01), Campbell et al.
patent: 2008/0085240 (2008-04-01), Flockhart et al.
Akutsu, Tomoko; Kobayashi, Kaoru; Sakurada, Koichi; Ikegaya, Hiroshi; Furihata, Tomomi; and Chiba, Kan; “Identification of Human Cytochrome P450 Isozymes Involved in DiphenhydramineN-Demethylation”; Drug Metabolism and Disposition; bearing a date of 2007; pp. 72-78; vol. 35, No. 1; The American Society for Pharmacology and Experimental Therapeutics; U.S.A.
Al Omari, Amal; and Murry, Daryl J.; “Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical Significance”; Journal of Pharmacy Practice; bearing a date of 2007; pp. 206-218; vol. 20.3; SAGE Publications.
“AmpliChip CYP450 Test for In Vitro Diagnostic Use”; Roche Diagnostics; bearing a date of Oct. 2007; pp. 1-36; Roche Molecular Systems, Inc.
Bailey, David G.; Malcolm, J.; Arnold, O.; and Spence, J. David; “Grapefruit juice-drug interactions”; British Journal of Clinical Pharmacology; bearing a date of 1998; pp. 101-110; vol. 46; Blackwell Publishing Ltd.
Beaird, Sandra L.; “HMG-CoA Reductase Inhibitors: Assessing Differences in Drug Interactions and Safety Profiles”; Journal of the American Pharmaceutical Association; bearing a date of 2000; pp. 637-644; vol. 40(5); American Pharmaceutical Association; found at http://www.medscape.com/viewarticle/406700.
Benet, Leslie Z.; and Cummins, Carolyn L.; “The drug efflux-metabolism alliance: biochemical aspects”; Advanced Drug Delivery Reviews; bearing a date of 2001; pp. S3-S11; vol. 50; Elsevier Science B.V.
Carruthers, S. George; Shoeman, Don W.; Hignite, Charles E.; and Azarnoff, Daniel L.; “Correlation between plasma diphenhydramine level and sedative and antihistamine effects”; Clinical Pharmacology & Therapeutics; bearing a date of Apr. 1978; vol. 23, No. 4: pp. 375-382.
Cederbaum, Arthur I.; “CYP2E1—Biochemical and Toxicological Aspects and Role in Alcohol-Induced Liver Injury”; The Mount Sinai Journal of Medicine; bearing a date of Jul. 2006; vol. 73, No. 4; pp. 657-672.
Chen, Jie; Yang, Xiao-Xia; Min, Huang; Hu, Ze-Ping; He, Ming; Duan, Wei; Chan, Eli; Sheu, Fwu-Shan; Chen, Xiao; and Zhou Shu-Feng; “Small Interfering RNA-Mediated Silencing of Cytochrome P450 3A4 Gene”; DMD Fast Forward; bearing a date of Jun. 7, 2006; as doi:10.1124/dmd.106.009837; pp. 1-48; American Society for Pharmacology and Experimental Therapeutics.
Coumoul, Xavier; Diry, Monique; Robillot, Cedric; and Barouki, Robert; “Differential Regulation of Cytochrome P450 1A1 and 1B1 by a Combination of Dioxin and Pesticides in the Breast Tumor Cell Line MCF-7”; Cancer Research; bearing a date of May 15, 2001; vol. 61; pp. 3942-3948.
“CYP3A4”; Wikipedia; pp. 1-6; found at http://en.wikipedia.org/wiki/CYP3A4; printed Nov. 7, 2008.
“Cytochrome P450”; Wikipedia; pp. 1-9; found at http://en.wikipedia.org/wiki/Cytochrome—P450; printed Nov. 7, 2008.
Dai, Yan; and Cederbaum, Arthur I.; “Inactivation and Degradation of Human Cytochrome P4502E1 by CCI4in a Transfected Hep62 Cell Line”; The Journal of Pharmacology and Experimental Therapeutics; bearing a date of 1995; pp. 1614-1622; vol. 275, No. 3; found at jpet.aspetjournals.org.
Do Rego, Amalia Cinthia Meneses; Filho, Irami Araujo; Damasceno, Bolivar P G L; Egito, Eryvaldo Socrates Tabosa; Da Silveira, Ivanaldo Amancio; Brandao-Neto, Jose; and Medeiros, Aldo Cunha; “Simvastatin improves the healing of infected skin wounds of rats”; Acta Cirurgica Brasileira; bearing a date of 2007; pp. 57-63; vol. 22, Supplement 1.
Girre, Catherine; Lucas, Daniele; Hispard, Eric; Menez, Catherine; Dally, Sylvain; and Menez, Jean-Francois; “Assessment of Cytochrome P4502E1 Induction in Alcoholic Patients by Chlorzoxazone Pharmacokinetics”; bearing a date of 1994; Biochemical Pharmacology; pp. 1503-1508; vol. 47, No. 9; Elsevier Science Ltd.
Guengerich, F. Peter; “Cytochrome P450 and Chemical Toxicology”; Chemical Research in Toxicology; bearing a date of 2008; pp. 70-83; vol. 21, No. 1; American Chemical Society.
Gupta, Rajesh; Plantinga, Laura C.; Fink, Nancy E.; Melamed, Michal L.; Coresh, Josef; Fox, Caroline S.; Levin, Nathan W.; and Powe, Neil R.; “Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease”; Journal of the American Medical Association; bearing a date of Apr. 4, 2007; pp. 1455-1464; vol. 297, No. 13; American Medical Association; located at http://jama.ama-assn.org/cgi/content/full/297/13/1455.
Gupta, Rajesh; Plantinga, Laura C.; and Powe, Neil R.; “Correction: Inaccurate Classification and Information Reported in a Study of Statin Use and Sepsis in Patients With Chronic Kidney Disease”; Journal of the American Medical Association; bearing a date of Feb. 20, 2008; pp. 765-766; vol. 299, No. 7; American Medical Association.
Hanna, Imad H.; Dawling, Sheila; Roodi, Nady; Guengerich, F. Peter; and Parl, Fritz F.; “Cytochrome P450 1B1 (CYP1B1) Pharmacogenetics: Association of Polymorphismms with Functional Differences in Estrogen Hydroxylation Activity”; Cancer Research; bearing a date of Jul. 1, 2000; pp. 3440-3444; vol. 60.
Hanukoglu, Israel; “Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis”; Laboratory of Steroid Molecular Biology; bearing a date of 1992; pp. 1-38.
Hedl, Matija; and Rodwell, Victor W.; “Inhibition of the Class II HMG-CoA reductase ofPseudomonas mevalonii”; Protein Science; bearing a date of 2004; pp. 1693-1697; vol. 13; Cold Spring Harbor Laboratory Press.
Hunter, Janice; and Hirst, Barry H.; “Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption”; Advanced Drug Delivery Reviews; bearing a date of 1997; pp. 129-157; vol. 25; Elsevier Science B.V.
Jaeschke, Hartmut; Gores, Gregory J.; Cederbaum, Arthur I.; Hinson, Jack A.; Pessayre, Dominique; and Lemasters, John J.; “Forum Mechanisms of Hepatotoxicity”; Toxicological Sciences; bearing a date of 2001; pp. 166-176; vol. 65; The Society of Toxicology.
Jenwitheesuk, Ekachai; Horst, Jeremy A.; Rivas, Kasey L.; Van Voorhis, Wesley C.; and Samudrala, Ram; “Novel paradigms for drug discovery: computational multitarget screening”; Trends in Pharmacological Sciences; bearing a date of Jan.
Bangera Mahalaxmi Gita
Hyde Roderick A.
Ishikawa Muriel Y.
Sweeney Elizabeth A.
Wood Victoria Y. H.
Raymond Edward
The Invention Science Fund I LLC
LandOfFree
Computational methods and systems for treatment in relation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Computational methods and systems for treatment in relation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Computational methods and systems for treatment in relation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4307296